MDxHealth Clinical Laboratory Receives CLIA Certification
MDxHealths 13,448-square-foot clinical laboratory facility in Irvine, Calif, has received CLIA certification of registration from the Centers for Medicare and Medicaid Services.
Read MoreSearch Results for: prostate cancer
Siemens Offers Replays of Oncology Webinars
Posted by Clinical Lab Products | Dec 14, 2011 | Cancer, Miscellaneous, Webcasts |
Each program has been designated for 1.0 PACE continuing education credit.
Read MoreNIH Offers Suggestion on Treatment of Prostate Cancer
Posted by Clinical Lab Products | Dec 9, 2011 | Cancer, Miscellaneous |
An independent panel convened by the NIH has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression.
Read MoreStudy: Quanterix PSA Reliable Predictor of BCR-Free Survival
Posted by Clinical Lab Products | Oct 13, 2011 | Cancer, Miscellaneous |
Quanterix Corp released results from a clinical evaluation of its Prostate Specific Antigen (PSA) test, a fifth-generation digital immunoassay.
Read MoreBioCurex Cancer Marker Blood Test More Accurate than FDA-Approved Free-PSA Test
Posted by Clinical Lab Products | Oct 11, 2011 | Cancer, Miscellaneous |
BioCurex Inc’s RECAF cancer marker blood test has been shown to detect approximately 70% of stage I, 76% of stage II, 90% of stage III, and 100% of stage IV prostate cancers all with very high specificity.
Read More